(lp0
S'Biocept Announces Revised Presentation Time at the 27th Annual Oppenheimer ... PR Newswire  - Mar 20, 2017 SAN DIEGO, March 20, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces a&nbsp;...Global Liquid Biopsy Market is Projected to Reach USD 450 Billion by 2022 - Digital Journal'
p1
aS'Biocept to Present at the 29th Annual ROTH Conference PR Newswire  - Mar 8, 2017 SAN DIEGO, March 8, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that&nbsp;...'
p2
aS'Biocept Inc  Stockholders Get Letter From The CEO Journal Transcript - Feb 27, 2017 A letter sent by the Michael Nall, the chief executive officer of Biocept Inc , to shareholders has sought to underscore the strong position the pharmaceutical company is currently in, in the area of liquid biopsy.'
p3
aS'Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy ... PR Newswire  - Mar 14, 2017 SAN DIEGO, March 14, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces a&nbsp;...Biocept  Enters Collaboration to Provide Liquid Biopsy Testing for Small ... - StreetInsider.com'
p4
aS'Valeant Pharmaceuticals Intl Inc  Running Low On Gas, Biocept Inc (BIOC ... Smarter Analyst - Mar 8, 2017 In the biotech-verse, Valeant Pharmaceuticals Intl Inc  and Biocept Inc  are in opposite standing. According to one of the best analysts on the Street, who has lately been zooming in with a vengeance on the troubled biotech giant ...Wall Street Movers News  Valeant Pharmaceuticals Intl Inc , Biocept ... - Wall Street Times '
p5
aS'How Does Biocept, Inc.  Stack Up Right Now? StockNewsJournal - Mar 23, 2017 Biocept, Inc.  is an interesting player in the Healthcare space, with a focus on Medical Laboratories &amp; Research.Taking a Look at the Chart for Biocept, Inc.  - The USA CommerceBiocept, Inc.  loses confidence of 2 hedge fund managers - Post Analyst'
p6
aS'Analyst Views And Outlook On Two Stocks: Biocept, Inc. , Actuant ... Post Analyst - 19 hours ago Biocept, Inc. has a consensus outperform rating from 2 Wall Street analysts, and the number of shares currently sold short amount to at least 20.18% of shares outstanding.'
p7
aS'Biocept Announces Pricing of $9.3 Million Financing PR Newswire  - 19 hours ago SAN DIEGO, March 28, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, today announced that it has entered into securities&nbsp;...'
p8
aS"Buy, Sell or Hold? Analysts Approach: Biocept, Inc. , Avon Products, Inc ... The USA Commerce - Mar 9, 2017 Shares of Biocept, Inc.  surged 0.44% to $2.27. During the trading on 03/08/2017, Company's stock ranged from $2.23 to $2.75."
p9
aS"What are Analyst's Indicators for EQT Corporation , Biocept, Inc.  The USA Commerce - Mar 24, 2017 Shares of EQT Corporation  surged 0.49% to $57.04. During the trading on 03/23/2017, Company's stock ranged from $57.71 to $56.33."
p10
a.